Return-Path: Received: from vps.transocean.com by vps.transocean.com with LMTP id oGtnD2zcn1pnWwAAInt2oQ ; Wed, 07 Mar 2018 04:34:52 -0800 Return-path: Envelope-to: JOHN@TRANSOCEAN.COM Delivery-date: Wed, 07 Mar 2018 04:34:52 -0800 Received: from mx.newscpt16.de ([185.11.253.150]:56906) by vps.transocean.com with esmtps (TLSv1.2:ECDHE-RSA-AES256-GCM-SHA384:256) (Exim 4.89_1) (envelope-from ) id 1etYHK-00065d-Dp for JOHN@TRANSOCEAN.COM; Wed, 07 Mar 2018 04:34:52 -0800 Content-Type: multipart/mixed; boundary="===============0050442064914778818==" DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=newscpt16.de; s=default; t=1520426008; bh=+AinUxEhG8du0aWQZVWE/eNnHD/ABUVaOUQSvJCNYKM=; h=X-CSA-Complaints:Reply-To:Subject:From:To:List-Id: List-Unsubscribe:Date:Reply-To:From:Subject:Date:To: List-Unsubscribe:List-Id:X-CSA-Complaints; b=GcIv7RVRNfbVhLQNliSfMB/svWnxDcMlw5VNVDb3Pzm4WZTHk9EhoYMSwcPflVQsN mPaXrQTUeAXFD6gl+6qBRquY10ggZKShiDV4rpq2FPyI6S/0VhMn8jXrZ3bH8zBAqR Rar/p69N2KhfMCrrsBeFMEs4f8iTXAy/9rM5fx/c= MIME-Version: 1.0 X-CSA-Complaints: Reply-To: FDA 2018 Changes Subject: Learn What Lies Ahead for the FDA under the New HHS Secretary Alex Azar From: FDA 2018 Changes To: BOUNCED_id_tdat_newsletter: 3551655 List-Id: <475626380> BOUNCED_id_tdat_nl_subscriber: 475626380 bounced_nl: true BOUNCED_tdat_nl_subscriber_pw: a2fbbf1269b6e082d34a526d26fed577 List-Unsubscribe: hermes_uid: 54b8ac3971b67cefc5f66ede8b4544e8 Date: Wed, 07 Mar 2018 12:33:28 -0000 Message-Id: <20180307123328.758DD24B267@mx.newscpt16.de> X-Spam-Status: No, score=1.6 X-Spam-Score: 16 X-Spam-Bar: + X-Ham-Report: Spam detection software, running on the system "vps.transocean.com", has NOT identified this incoming email as spam. The original message has been attached to this so you can view it or label similar future email. If you have any questions, see root\@localhost for details. Content preview: Sie können diesen HTML Newsletter nicht sehen? Dann verpassen Sie wirklich etwas. Rufen Sie folgende URL auf, um den Newsletter anzuzeigen: http://ea.newscpt16.de/_ns/c28609950c02ce5aa72f3dbd0bb8c613.html [...] Content analysis details: (1.6 points, 3.0 required) pts rule name description ---- ---------------------- -------------------------------------------------- 0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was blocked. See http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block for more information. [URIs: audioeducator.com] -0.0 SPF_PASS SPF: sender matches SPF record -0.0 T_RP_MATCHES_RCVD Envelope sender domain matches handover relay domain 0.2 HEADER_FROM_DIFFERENT_DOMAINS From and EnvelopeFrom 2nd level mail domains are different 0.0 HTML_MESSAGE BODY: HTML included in message 0.8 BAYES_50 BODY: Bayes spam probability is 40 to 60% [score: 0.5000] 0.0 HTML_FONT_LOW_CONTRAST BODY: HTML font color similar or identical to background 0.6 KAM_ADVERT2 RAW: This is probably an unwanted commercial email... 0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily valid -0.1 DKIM_VALID Message has at least one valid DKIM or DK signature 0.0 T_HTML_TAG_BALANCE_CENTER Malformatted HTML X-Spam-Flag: NO --===============0050442064914778818== Content-Type: multipart/alternative; boundary="===============1205717772181660701==" MIME-Version: 1.0 --===============1205717772181660701== MIME-Version: 1.0 Content-Transfer-Encoding: 8bit Content-Type: text/plain; charset="utf-8" Sie können diesen HTML Newsletter nicht sehen? Dann verpassen Sie wirklich etwas. Rufen Sie folgende URL auf, um den Newsletter anzuzeigen: http://ea.newscpt16.de/_ns/c28609950c02ce5aa72f3dbd0bb8c613.html Um sich von diesem Newsletter abzumelden, rufen Sie folgende URL auf: http://ea.newscpt16.de/_u/c28609950c02ce5aa72f3dbd0bb8c613.html /// Can't see this html newsletter? You're really missing out. Visit this URL to view the newsletter: http://ea.newscpt16.de/_ns/c28609950c02ce5aa72f3dbd0bb8c613.html To instantly unsubscribe from our newsletter, visit this URL: http://ea.newscpt16.de/_u/c28609950c02ce5aa72f3dbd0bb8c613.html --===============1205717772181660701== MIME-Version: 1.0 Content-Transfer-Encoding: 8bit Content-Type: text/html; charset="utf-8" Implications of Alex Azar as Head of Health & Human Services
Implications of Alex Azar as Head of Health
and Human Services
Presented By: Norma Skolnik
Live Webinar
Date: Tuesday, March 13, 2018 | Duration: 60 minutes
Time: 1 pm ET | 12 pm CT | 11 am MT | 10 am PT
REGISTER NOW
FDA Policy Changes, Drùg Pricing, the ACA and More: What Lies Ahead under the New HHS-Head, Alex Azar?
President Trump confirmed Alex Azar to be the new Health and Human Services (HHS) secretary, which will have an important impact on HHS in general and the FDA in particular. Join this session, where regulatory expert Norma Skolnik will explorè the implications of Alex being the new secretary of the HHS. This session will provide a background on Alex, President Trump’s new Head of the Department of HHS.

The session will further cover the likely trends that may be expected under Alex’s administration based on his background and statements made at his confirmation hearing.  Norma will explorè Alex’s potential impact on the future of the FDA, drùg and device regulations, drùg pricing, and the drùg approval process. She will also discuss Alex’s attitude toward Medìcaid and Medìcare. You will get references to all relevant regulations and documentation. Read more
Session Highlights
  • Alex Azar’s history and background, and statements made during his confirmation hearing
  • President Trump’s stated intentions to address drùg pricing and where Alex stands on the issue
  • Past policies that HHS-head, Alex, has supported, as well as his likely intentions for HHS programs
  • Key issues facing HHS that Alex is likely to address, such as the Affordable Care Act, drùg pricing, patent
  • And more
  CLICK HERE TO REGISTER  
Get answers to your questions in the Q&A directly from the speaker
Savè upto 90% with AudioEducator’s Annual License
Know More!
✆ Call now at 1-866-458-2965 or email at customerservice@audioeducator.com (Reference codè: EFOOKB0D_CE)
About Our Speaker
Norma Skolnik Norma Skolnik has over 35 years of regulatory experience working with the pharmaceutical and dietary supplement industries. She served as Director of Regulatory Affairs for the Americas for Cadbury Adams. Read more
Follow Us On: fb tw linkedin yt Knowledge for Healthcare

We hope you found this message to be useful.
If you don’t wish to receive any further communication, please click the unsubscribe link below. Your request will be processed within 10 days. This is an advertisement.
Audio Educator | 2222 Sedwick Rd, Durham NC 27713 | 1-866-458-2965
This message has been sent by Audio Educator.

UNSUBSCRIBE --===============1205717772181660701==-- --===============0050442064914778818==--